JAMES WALTERS: Open Payments
NPI 1528814423 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $89 |
| Medtronic, Inc. | 2 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| PFIZER INC. | 3 | $69 |
| Novo Nordisk Inc | 4 | $68 |
| Lilly USA, LLC | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ABBVIE INC. | 2 | $39 |
| Abbott Laboratories | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: TRELEGY ELLIPTA, REXULTI, INTELLIS ADAPTIVESTIM, NURTEC ODT, MOUNJARO, AIRSUPRA, Wegovy, Ozempic.
Industry payments across VA — which companies pay providers there.
